Telmisartan 40 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB26FJRWS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,120
Award facts
- Contract value 100% obligated
- $1,120.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,120.16 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Telmisartan 40 mg tablets (30-count units). The award was issued on October 27, 2025, with an ultimate completion date of October 28, 2025, under a firm fixed-price arrangement with no set-aside designation. This delivery order is issued pursuant to DMS Pharmaceutical Group's single-award Indefinite Delivery Contract under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion contract awarded on November 13, 2025, that authorizes DLA to procure a comprehensive range of pharmaceutical products to support Department of Defense military healthcare facilities worldwide.
DMS Pharmaceutical Group has demonstrated substantial federal contracting activity as a critical pharmaceutical supplier within the DoD medical supply chain, with recent delivery orders spanning oncology treatments, biologics, vaccines, emergency medications, and routine pharmaceuticals. The vendor's established performance across multiple product categories and pricing ranges, combined with its small business status, positions it competitively within the broader $30.3 billion PPV-G GEN V acquisition strategy. The company maintains no identified subcontractor relationships and operates as a direct supplier to federal agencies, leveraging its comprehensive pharmaceutical distribution capabilities to fulfill specialized medical supply requirements for military healthcare operations.
Quick answers
Who was awarded contract SPE2DB26FJRWS?
SPE2DB26FJRWS was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FJRWS worth?
The government has obligated $1,120 on SPE2DB26FJRWS.
Is contract SPE2DB26FJRWS an order under another contract?
Yes. SPE2DB26FJRWS is a delivery order under SPE2DB24D9803, an indefinite delivery contract.
Was contract SPE2DB26FJRWS competed?
The extent of competition for SPE2DB26FJRWS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award